At present 33% of US adults are overweight and are in the 40-59 age group
The LEAN trial demonstrated that liraglutide achieved NASH resolution in 39% of patients versus 9% with placebo
Alcohol: The company's provider guides advise limiting or avoiding alcohol during treatment, especially during dose adjustments, as it may worsen nausea, low blood sugar, or dehydration
This includes, among other things, requirements of the FD&C Act related to bulk drug substances
Better liver health: Semaglutide significantly reduces liver fat in people with fatty liver disease
Furthermore, tubuloids obtained via urine from cystic fibrosis patients were used to assess treatment efficacy and circumvented the use of an invasive method to obtain patient material (Schutgens et al